Navigation Links
Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals
Date:12/9/2009

These forward-looking statements include statements regarding forecasts of product development and other matters that involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from those referred to in the forward-looking statements. Such risks include, but are not limited to, the risk of whether certain market segments grow as anticipated; clinical trial results; the competitive environment in the biotechnology industry; and whether Anesiva can successfully develop new products and the degree to which these gain market acceptance as well as other risks detailed from time to time in Anesiva's filings with the Securities and Exchange Commission ("SEC"), including Anesiva's most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2008, its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K as filed with the SEC. Anesiva expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SOURCE Anesiva, Inc.


'/>"/>
SOURCE Anesiva, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
2. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
3. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
4. Anesiva Defines Regulatory Pathway for Adlea with FDA
5. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
6. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
7. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
8. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
9. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
10. Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
11. Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014 /CNW/ - On Aug. 20, at its ... Canadian Medical Association (CMA) voted on and approved a ... including medicinal cannabis. Bedrocan Cannabis Corp., a leading Canadian ... CMA motion. The CMA is quite right ... with smoking any plant material, including medicinal cannabis. While ...
(Date:8/22/2014)... -- MC Medical, a subsidiary of Mitsubishi Corporation (MCM), and ... medical device company, have formally agreed to an ... system in Japan . It is anticipated ... Japan in the latter half of 2015. ... portfolio in endoscopic surgery market in Japan ...
(Date:8/22/2014)... 2014 Research and Markets has ... Particulate Respirators Industry Report 2014" report to their ... Respirators Industry Report 2014 is a professional and in-depth ... respirators industry with a focus on the Chinese situation. ... industry including definitions, classifications, applications and industry chain structure. ...
Breaking Medicine Technology:Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Global and Chinese Particulate Respirators Industry Report 2014 2
... , MORRISTOWN, N.J., Dec. 14 Watson ... new program encouraging health professionals to help maintain the bone ... deprivation therapy (ADT). Nearly two million men are receiving ... effective and considered the "gold therapy," can cause bone loss ...
... , DOVER, Del., Dec. 14 Ohr Pharmaceutical ... selected Allen & Caron Inc, headquartered in Irvine, CA, ... its agency for investor relations and corporate communications. ... on developing advanced drugs for underserved therapeutic needs. The ...
Cached Medicine Technology:Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3
(Date:8/22/2014)... Aug. 22, 2014 (HealthDay News) -- Many Americans know little ... the possibility of an outbreak in the United States, a ... they are worried that there will be a major Ebola ... they or an immediate family member will get sick with ... latest Harvard School of Public Health poll. However, those ...
(Date:8/22/2014)... Natural Clear Vision , a how-to ... own vision from legally blind to perfect 20/20 vision has ... , “There is a huge portion of the population ... and most people just think that’s the way it will ... can be pretty risky at times,” reports Michaels. “This program ...
(Date:8/22/2014)... deletion in advanced non-small cell lung cancer (NSCLC) ... in epidermal growth factor receptor (EGFR) tyrosine kinase ... BIM deletion independently predicts overall survival (OS) of ... activate the programmed cell death also known as ... been detected in 12.8% of the Asian population ...
(Date:8/22/2014)... DETROIT Rheumatoid arthritis (RA), a complex autoimmune ... adults, requires patients to not only cope with ... stressors such as disrupted work, family life and ... RA patients, residual pain and disability is common. ... to their high cost or side effects. Because ...
(Date:8/22/2014)... Advancements in ultrasound technologies make them ... to their cost-effectiveness, non-invasiveness, and absence of radiation. ... as the evolution of wireless transducers and real-time ... moving throughout 2014 and beyond. Such Ultrasound’s key ... the point-of-care (POC) testing in hospital settings, but ...
Breaking Medicine News(10 mins):Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3
... facts and figures has shown the dangerous increase in Type ... The number of children below five years of age, battling ... between 1985 and 2004. ,Type 1 diabetes or ... as opposed to Type 2 diabetes, which develops much later. ...
... might one day help block the spread of an illness ... ,When they fed on malaria-infected mice, the resistant ... they could eventually replace the ones that can carry the ... of the National Academy of Sciences. ,Jason Rasgon ...
... are fueling the spread of HIV in Afghanistan, the New ... there are 69-recorded cases of HIV in the country; however, ... much higher. The World Health Organization estimates that about 1,000 ... a World Bank consultant on HIV/AIDS, said the WHO estimate ...
... could result in cardio-vascular diseases, it is known. Now ... a deadlier combination. , ,At a conference ... capital of the north Indian state of Uttar Pradesh, ... condition called metabolic syndrome (MS). ,It is ...
... awareness day. This ‘celebration’ acquires specific significance in India,// ... day, 500,000 people are reported to suffer a head ... sixth most common cause of death, in the country. ... a person suffers a brain injury as a result of severe ...
... has come out strongly against the use of sunbeds or ... ,According to the Working Group on artificial UV light ... Cancer (IARC), persons who use these tanning beds in order ... themselves to higher risks of developing melanoma, the most dreaded ...
Cached Medicine News:Health News:Malaria-resistant Mosquito Developed 2Health News:Stigma, Lack of Education, Prevent the Spread of HIV in Afghanistan 2Health News:Head Injury Awareness Day 2Health News:Head Injury Awareness Day 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: